Skip to main content
DRIO logo

DRIO · DarioHealth Corp. · Financials

Track DRIO — free
$2.38 -0.35 (-12.84%) At close · Nov 6 Q1 2026 earnings call transcript
Market Cap
$23.27M
Shares
9.80M
Volume · Nov 6 14.9K Avg daily vol (3M) 38.18K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$22.36M -17.3%
FY2025 Revenue FY2013–FY2025
Net Income
-$41.71M +2.4%
FY2025 Net Income FY2012–FY2025
Gross Margin
56.64% +7.6pp
FY2025 Gross Margin FY2014–FY2025
Operating Margin
-163.94% +49.6pp
FY2025 Operating Margin FY2014–FY2025
Diluted EPS
$10.12 -17.5%
FY2025 Diluted EPS FY2020–FY2025
Operating Cash Flow
-$25.94M +32.7%
FY2025 Operating Cash Flow FY2012–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
$21M $22.36M $27.04M $20.35M $27.66M $20.51MG $7.58M $7.56M $7.39M $5.17M $2.8M $823K $51K $0 —
$8.79M $9.69M $13.77M $14.37M $18M $16.55M $5.06M $4.96M $5.63M $3.86M $3.36M $1.68M $2.27M $0 —
$12.21M $12.67M $13.27M $5.98M $9.66M $3.96M $2.51M $2.6M $1.77M $1.31M -$830K -$855K -$2.71M $0 —
— 56.64% 49.06% 29.4% 34.91% 19.32% 33.17% 34.36% 23.87% 25.36% -29.61% -103.89% -5317.65% — —
$10.45M $13.79M $24.18M $20.25M $19.65M $17.22M $4.43M $3.69M $3.68M $3.3M $2.15M $2.57M $3.94M $4.91M $1.5M
$14.5M $15.19M $20.48M $18.14M $16.49M $23.53M $12.76M $5.48M $5.47M $4.73M $3.38M $2.95M $3.64M $6.3M $2.18M
$1.88M $2.83M $6.1M $4.51M $4.36M $4.18M — — — — — — — — —
$44.05M $49.32M $71.01M $62.17M $66.47M $80.46M $32.42M $20.3M $19.45M $15.73M $10.27M $6.84M $8.65M $13.56M —
-$31.83M -$36.66M -$57.74M -$56.19M -$56.81M -$76.49M -$29.9M -$17.71M -$17.69M -$14.42M -$11.1M -$7.7M -$11.36M -$13.56M -$3.97M
— -163.94% -213.55% -276.09% -205.42% -372.9% -394.71% -234.22% -239.22% -278.9% -396.04% -935.36% -22270.59% — —
— $3.02M — — — — — — — — — — — — —
$712K $943K $1.12M $1.87M $506K $44K $61K $16K $0 — — — — — —
-$3.37M -$4.95M $13.15M -$3.17M -$5.38M -$235K $458K -$31K -$115K -$1.32M $214K $556K -$1.52M -$369K -$1.71M
-$35.2M -$41.61M -$44.6M -$59.36M -$62.19M -$76.73M -$29.45M -$17.74M -$17.8M -$15.74M -$10.89M -$7.14M $12.88M $13.93M $5.69M
$468K $105K -$1.85M $64K $4000 $32K — — — — — — — — —
-$35.67M -$41.71M -$42.75M -$59.43M -$62.19M -$76.76M -$29.45M -$17.74M -$17.8M -$15.74M -$10.89M -$7.14M -$12.88M -$13.93M -$5.69M
— -186.56% -158.09% -292% -224.88% -374.21% -388.66% -234.63% -240.78% -304.51% -388.41% -867.8% -25249.02% — —
— — — — -$59.96M -$67.52M -$33.1M -$20.89M -$18.3M -$16M -$11.61M -$7.3M -$16.06M -$13.93M —
-$45.28M -$61.74M -$40.98M -$63.51M -$63.84M -$78.77M — — — — — — — -$13.93M -$5.69M
USD/shares $5.81 $10.12 $12.27 $38.60 $50.80 $81.40 $80.20 — — — — — — — —
USD/shares $5.81 $10.12 $12.27 $38.60 $50.80 $81.40 $80.20 — — — — — — — —
shares — 3.98M 2.45M 1.42M 1.18M 829.59K 298.17K 113.31K 58.53K 481.41K 260.15K 94.89K 433.95K 183.13K 618.75K
shares — 3.98M 2.45M 1.42M 1.18M 829.59K 298.17K 113.31K 58.53K 481.41K 260.15K 94.89K 433.95K 183.13K 618.75K
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-06-30 USD 572,000 10-Q filed 2026-08-11
Noncurrent debt carrying amount 2026-06-30 USD 31,064,000 10-Q filed 2026-08-11
Noncurrent operating lease liabilities 2026-06-30 USD 777,000 10-Q filed 2026-08-11
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
1.92×
Peer median 0.40×
EV/EBIT
—
P/E (TTM)
—
Peer median 29.00×
Price/Sales (TTM)
1.11×
Peer median 1.03×
Price/Book
0.42×
Peer median 0.98×

Peer medians compare against the 21 similar-size Health Information Services companies (of 52 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Service $14,929,000 $20,197,000 $13,084,000 $17,859,000 $2,085,000 $1,809,000
Hardware and Consumable Products $7,430,000 $6,843,000 $7,268,000 $9,797,000 $18,428,000 —
Commercial — — — $16,377,000 $851,000 —
Consumers — — $8,293,000 $11,279,000 $19,662,000 —
Development Services Per Exclusive Agreement — — $4,592,000 $5,506,000 — —
Development Services Per Exclusive Agreement Year One — — — $4,000,000 — —
Development Services Per Exclusive Agreement Year Three — — $2,098,000 — — —
Development Services Per Exclusive Agreement Year Two — — $2,494,000 $1,506,000 — —
National Health Plan Statement of Work Agreement — — $962,000 $1,778,000 — —
Sales Channel Business to Business to Consumer (B2B2C) — — $5,005,000 $3,593,000 — —
Sales Channel Strategic Partnerships — — $7,054,000 $12,784,000 — —
Product — — — — $17,793,000 $5,767,000
Key facts CIK 1533998 CUSIP 23725P308 13F (30d) 12 filings 6 filers Visit website Investor relations